Response assessment criteria and their applications in Lymphoma: Part 2

Mateen C. Moghbel; Erik Mittra; Andrea Gallamini; Ryan Niederkohr; Delphine L. Chen; Katherine Zukotynski; Helen Nadel; Lale Kostakoglu

doi:10.2967/jnumed.116.184242

Response assessment criteria and their applications in Lymphoma: Part 2

Mateen C. Moghbel, Erik Mittra, Andrea Gallamini, Ryan Niederkohr, Delphine L. Chen, Katherine Zukotynski, Helen Nadel, Lale Kostakoglu

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Abstract

Interim and end-of-Treatment PET/CT have become central to the evaluation of Hodgkin and non-Hodgkin lymphoma. This review article seeks to aid clinical decision making by providing an overview of available data on the diagnostic and prognostic value of PET/CT imaging for response assessment and pretransplant evaluation in lymphoma. The relative strengths and limitations of these techniques in various disease subtypes and clinical scenarios are explored, along with their current standards for reporting and latest developments. Particular attention is given to response-Adapted therapy, which is emerging as a cornerstone of clinical management.

Original language	English (US)
Pages (from-to)	13-22
Number of pages	10
Journal	Journal of Nuclear Medicine
Volume	58
Issue number	1
DOIs	https://doi.org/10.2967/jnumed.116.184242
State	Published - Jan 1 2017
Externally published	Yes

Keywords

Lymphoma
PET/CT response assessment
Responseadapted therapy

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.2967/jnumed.116.184242

Cite this

@article{51e0d006fa8a408082d194d4d2691d9a,

title = "Response assessment criteria and their applications in Lymphoma: Part 2",

abstract = "Interim and end-of-Treatment PET/CT have become central to the evaluation of Hodgkin and non-Hodgkin lymphoma. This review article seeks to aid clinical decision making by providing an overview of available data on the diagnostic and prognostic value of PET/CT imaging for response assessment and pretransplant evaluation in lymphoma. The relative strengths and limitations of these techniques in various disease subtypes and clinical scenarios are explored, along with their current standards for reporting and latest developments. Particular attention is given to response-Adapted therapy, which is emerging as a cornerstone of clinical management.",

keywords = "Lymphoma, PET/CT response assessment, Responseadapted therapy",

author = "Moghbel, {Mateen C.} and Erik Mittra and Andrea Gallamini and Ryan Niederkohr and Chen, {Delphine L.} and Katherine Zukotynski and Helen Nadel and Lale Kostakoglu",

year = "2017",

month = jan,

day = "1",

doi = "10.2967/jnumed.116.184242",

language = "English (US)",

volume = "58",

pages = "13--22",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

number = "1",

}

TY - JOUR

T1 - Response assessment criteria and their applications in Lymphoma

T2 - Part 2

AU - Moghbel, Mateen C.

AU - Mittra, Erik

AU - Gallamini, Andrea

AU - Niederkohr, Ryan

AU - Chen, Delphine L.

AU - Zukotynski, Katherine

AU - Nadel, Helen

AU - Kostakoglu, Lale

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Interim and end-of-Treatment PET/CT have become central to the evaluation of Hodgkin and non-Hodgkin lymphoma. This review article seeks to aid clinical decision making by providing an overview of available data on the diagnostic and prognostic value of PET/CT imaging for response assessment and pretransplant evaluation in lymphoma. The relative strengths and limitations of these techniques in various disease subtypes and clinical scenarios are explored, along with their current standards for reporting and latest developments. Particular attention is given to response-Adapted therapy, which is emerging as a cornerstone of clinical management.

AB - Interim and end-of-Treatment PET/CT have become central to the evaluation of Hodgkin and non-Hodgkin lymphoma. This review article seeks to aid clinical decision making by providing an overview of available data on the diagnostic and prognostic value of PET/CT imaging for response assessment and pretransplant evaluation in lymphoma. The relative strengths and limitations of these techniques in various disease subtypes and clinical scenarios are explored, along with their current standards for reporting and latest developments. Particular attention is given to response-Adapted therapy, which is emerging as a cornerstone of clinical management.

KW - Lymphoma

KW - PET/CT response assessment

KW - Responseadapted therapy

UR - http://www.scopus.com/inward/record.url?scp=85009113882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009113882&partnerID=8YFLogxK

U2 - 10.2967/jnumed.116.184242

DO - 10.2967/jnumed.116.184242

M3 - Article

C2 - 27879369

AN - SCOPUS:85009113882

SN - 0161-5505

VL - 58

SP - 13

EP - 22

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 1

ER -

Response assessment criteria and their applications in Lymphoma: Part 2

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this